Quick Finance Updates

[jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]

  • Canara Bank Properties Q3 net profit rises at Rs.317.5 crore – 28th Jan 2019
    Canara Bank reported Q3 results for the quarter ended Dec 31, 2018:
    Net interest income up 4% y-o-y to Rs. 3,813.80 crore versus Rs. 3,679 crore.
    Net profit at Rs. 317.52 crore from Rs. 125.75 crore.
    Gross non-performing assets as a percentage of total advances at 10.25% versus 10.56% (QoQ) & Provisions for NPAs at Rs. 2,732.71 crore versus Rs. 2,403.06 crore (QoQ).
  • Godrej Properties Q3 net profit at Rs.41.6 crore – 28th Jan 2019
    Godrej Properties reported Q3 results for the quarter ended Dec 31, 2018:
    Net profit at Rs. 41.6 crore versus net loss of Rs. 54.8 crore.
    Revenue rose by 27.2% y-o-y to Rs. 340.1 crore from 267.4 crore.
    EBITDA net loss at Rs. 38.7 crore versus net loss of Rs. 60.5 crore.
  • City Union Bank Q3 net profit rises by 15% yoy – 28th Jan 2019
    City Union Bank reported Q3 results for the quarter ended December 31, 2018:
    Net profit rose by 15.1% y-o-y to Rs. 178.1 crore from Rs. 154. 8 crore.
    NII gained 14.4% to Rs. 417.7 crore from Rs. 365.1 crore.
  • Gruh Finance reported Q3 net profit rises by 6.8% yoy – 28th Jan 2019
    Gruh Finance reported Q3 results for the quarter ended December 31, 2018:
    Net profit up by 6.8% to Rs. 97 crore versus Rs 90.8 crore.
    Net interest income down by 7.7% to Rs. 166.7 crore.
    Provisions and write-offs of Rs. 26 crore in base quarter.
  • Gati Q3 net profit rises by 27.6% yoy – 28th Jan 2019
    Gati reported Q3 results for the quarter ended December 31, 2018:
    Net profit rose by 27.6% at Rs. 3.7 crore.
    Revenue gained 7.2% at Rs. 480.6 crore.
    Ebitda flat at Rs. 24 crore & margins at 5% versus 5.3%.
  • Maruti Suzuki Q3 net profit falls by 17% yoy – 25th Jan 2019
    Maruti Suzuki reported Q3 results for the quarter ended December 31, 2018:
    Net profit down by 17% y-o-y to Rs. 1,489.30 crore versus Rs. 1,799 crore
    Revenue up by 2% y-o-y to Rs. 19,668 crore versus Rs. 19,283 crore
    Ebitda down by 36% y-o-y to Rs. 1,930 crore versus Rs. 3,038 crore
  • Indian Bank Q3 net profit falls by 49.8% yoy – 25th Jan 2019
    Indian Bank reported Q3 result for the Quarter ended December 31, 2018:
    Net profit slipped by 49.8% y-o-y to Rs. 152.3 crore from Rs. 303.3 crore
    NII rose by 5.8% y-o-y to Rs. 1,717 crore from Rs. 1,622.8 crore
  • Kirloskar Oil Engines Q3 net profit rises by 6.5% yoy – 25th Jan 2019
    Kirloskar Oil Engines reported Q3 results for the Quarter ended December 31, 2018:
    Net profit rose by 6.5% y-o-y to Rs. 42 crore versus Rs. 39.45 crore
    Revenue rose by 13% y-o-y to Rs. 774.31 crore versus Rs. 684.61 crore
  • Quess Corp Q3FY19 operating performance came in line
    Quess Corp Q3FY19 consolidated results – operating performance came in line; lower tax led to better than expected PAT. Quess Corp revenues grew by 37.1% in Q3FY19 largely on back of 46.0% growth in people & service management business and 33% growth in the global technology business. The operating profit stood almost flat at 29BPS to 5.4% and the operating profit grew by 30.1%yoy to Rs. 118.3 crore. The lower other income, higher interest cost and depreciation charges led to just 16.3% y-o-y growth in the adjusted PAT at Rs. 69.9 crore. The same was ahead of our expectation mainly on account of lower incidence of tax during the quarter.
  • Biocon Q3 FY 2019 results above expectation
    Sales for the quarter grew by 45.6% to Rs. 1540.8 crore; Operating profit grew by 84.4% to Rs. 408.8 crore; OPM improved by 53 bps to 26.5%; Adjusted profit grew by 129.8% to Rs. 211.4 crore. Pegfilgrastim launch in US led to doubling of revenue of biologics segment. Small Molecules, Branded Formulations and Research Services also registered a robust growth this quarter. Biosimilar Pegfilgrastim (Fulphila) and biosimilar Trastuzumab (Ogivri), co-developed by Biocon and Mylan, received marketing approvals in EU. Biosimilar Insulin Glargine (Semglee®) and biosimilar Adalimumab were launched in EU by partner Mylan. Company has launched Atorvastatin Calcium tablets in the U.S. New Oral Solid Dosage Forms manufacturing facility in Bengaluru completed a pre-approval inspection by the USFDA with no 483 observations. API manufacturing facility in Telangana successfully completed a GMP audit by the USFDA with no 483 observations.
  • Yes Bank reports Q3 net profit at Rs. 1,001 crore
    Yes Bank reported Q3 results for the quarter ended December 31, 2018:
    Net profit at Rs. 1,002 crore versus Rs 1,077 crore (YoY)
    Net interest income up by 41% y-o-y to Rs. 2,666.41 crore from 1,889 crore
    Gross non-performing assets as a percentage of total advances at 2.10% versus 1.60 percent (QoQ)
    Net non-performing assets as a percentage of total advances at 1.18% versus 0.84% (QoQ)
    Provisions for bad loans down 41% at Rs. 550 crore
    Ravneet Gill to joined Yes Bank as Managing Director and CEO with effect from March 1.
  • Edelweiss Q3 net profit falls by 4% y-o-y
    Edelweiss Financial Services reported Q3 results for the quarter ended December 31, 2018:
    Net profit down by 4% y-o-y to Rs. 226 crore from Rs. 235 crore
    Revenue up by 26% y-o-y to Rs. 2,776 crore from Rs. 2,205 crore
    Net interest income rose by 28.8% y-o-y to Rs. 1,562.9 crore from Rs, 1,213.5
    Announced dividend of Rs. 1.10 per share
  • ITC Q3 net profit rises by 4% y-o-y
    ITC reported Q3 results for the quarter ended December 31, 2018:
    Net profit up by 4% y-o-y to Rs. 3,209 crore versus Rs. 3,090 crore
    Revenues rose by 15% y-o-y to Rs. 11,227 crore versus Rs. 9,772 crore
    EBITDA gained 11% to Rs. 4,325.5 crore versus Rs. 3,889 crore
  • Raymond Q3 net profit surges by 30% y-o-y
    Raymond reported Q3 results for the quarter ended December 31, 2018:
    Net profit up 30% y-o-y to Rs. 37.56 crore from Rs. 28.84 crore
    Revenue at Rs. 167.51 crore versus Rs. 148.42 crore (YoY)
  • Colgate-Palmolive Q3 net profit at Rs. 192 crore
    Colgate-Palmolive reported Q3 result for the quarter ended December 31, 2018
    Net profit down by 12.3% y-o-y to Rs. 192 crore versus Rs. 171 crore
    Revenues up by 6.5% y-o-y to Rs. 1,099 crore versus Rs. 1,032 crore
    EBITDA up 11.6% y-o-y to at Rs. 315 crore versus Rs. 282 crore
    EBITDA margin at 28.6% versus 27.3%
  • UltraTech Cement reports Q3 net profit at Rs. 449 crore
    UltraTech Cement posted Q3 result for the quarter ended December 31, 2018:
    Net profit up by 6.5% y-o-y to Rs. 449 crore from Rs. 421 crore
    Revenue surged by 18% y-o-y to Rs. 8,812.72 crore from Rs. 7,471 crore
    EBITDA increased by 9.6% to Rs. 1,390 crore from Rs 1,268.5 crore
    Margin at 15.8% versus 17%
    Other income at Rs. 124 crore versus Rs. 155.57 crore (YoY)
  • NIIT reports decline in net profit for Q3
    NIIT reported Q3 results for the quarter ended December 31, 2018:
    Net profit slipped by 1.5% y-o-y to Rs. 19.5 crore from 19.7 crore
    Revenue gained 8.8% y-o-y to Rs. 227.8 crore from 209.4 crore
  • Glenmark gets USFDA nod for Topiramate ER capsules
    Glenmark Pharmaceuticals received United States Food & Drug Administration (USFDA) nod for Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg, a generic version of QUDEXY 1 XR Extended-Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg, of Upsher-Smith Laboratories, LLC.
    At 11.55 am, Glenmark Pharmaceuticals was trading at Rs. 648.80, down by 0.17%, with a volume of 0.16 lakh shares on the BSE.
  • [jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]

  • 4 Replies to “Quick Finance Updates

    Leave a Reply